IGF1 and central nervous system cancer: Targeted ablation of IGF1 in M/T cells has been demonstrated to effectively curtail the proliferation of mutated oligodendrocytes and to impede tumor progression, emphasizing the critical role of IGF‐1 in glioma development [46].